Cellvantix

Clinical Study
on Blood Sugar Support

Effect of Emulin on Blood Glucose in Type 2 Diabetics
Published in Journal of Medicinal Food – March 2013

Up to 20% Improvement in
Blood Sugar Parameters

5-25%

WORSENING 

Placebo group (got worse over time)

1-5%

IMPROVEMENT

EMULIN alone (performed as well as medication)

UP TO 20%

IMPROVEMENT

EMULIN + standard medication (best results)

Study Design

40 people with confirmed type 2 diabetes tested over 1 week across 4 groups comparing EMULIN to placebo and standard medication.

Key Management

“These results suggest that Emulin, if consumed regularly, could not only have the acute effect of lowering the glycemic impact of foods, but chronically lower background blood glucose levels.”

Published Research Conclusion,
Journal of Medicinal Food

Clinical Significance: This study demonstrates that EMULIN® works synergistically with the body’s natural processes and may enhance the effectiveness of standard blood sugar management approaches.

Disclaimers: The data shown are from one clinical study under specific conditions; individual results may vary. This information is for educational purposes only not medical advice. Always consult your healthcare provider. These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

shopping cart